Skip to main content
. 2021 Oct 10;41:100424. doi: 10.1016/j.dmpk.2021.100424

Table 4.

Topics related to the pharmacokinetics of lipid nanoparticles.

Active ingredient
(Company)
Patisiran
(Alnylam)
Tozinameran
(Pfizer/BioNTech)
Administration route intravenous intramuscular
Primary biodistribution liver injection site
Biodegradable property in ionizable lipid no yes
Anti-drug antibody (ADA) assessments anti-PEG antibody not reported